Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines

Neuropsychopharmacology

Volumn 29, Issue 7, 2004, Pages 1282-1293

  Lähdesmäki, Janne ^a   Sallinen, Jukka ^b   MacDonald, Ewen ^c   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ORION CORPORATION   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Adrenergic; Alpha 2; Dextroamphetamine; Genetically modified; Mice; Norepinephrine; Receptors; Sensorimotor gating; Startle reaction

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; BRAIN MONOAMINE; DEXAMPHETAMINE; DEXMEDETOMIDINE; NORADRENALIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; BEHAVIOR; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN DEPLETION; STARTLE REFLEX; WILD TYPE;

ACOUSTIC STIMULATION; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; ELECTRIC STIMULATION; FEMALE; IMIDAZOLES; INHIBITION (PSYCHOLOGY); MALE; MICE; MICE, KNOCKOUT; RECEPTORS, ADRENERGIC, ALPHA-2; STARTLE REACTION;

EID: 2942689967     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300428     Document Type: Article

References (59)

1. Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K et al (1999). Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol 56: 154-161.
2. Arnold LE, Huestis RD, Smeltzer DJ, Scheib J, Wemmer D, Colner G (1976). Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating. Arch Gen Psychiatry 33: 292-301.
3. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
4. Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S et al (2002). Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106: 2491-2496.
5. Bücheler MM, Hadamek K, Hein L (2002). Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience 109: 819-826.
6. Darracq L, Blanc G, Glowinski J, Tassin JP (1998). Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18: 2729-2739.
7. Davis M, Astrachan DI (1981). Spinal modulation of acoustic startle: opposite effects of clonidine and D-amphetamine. Psychopharmacology (Berl) 75: 219-225.
8. Davis M, Cedarbaum JM, Aghajanian GK, Gendelman DS (1977). Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats. Psychopharmacology (Berl) 51: 243-253.
9. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S et al (2002). Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22: 2873-2884.
10. Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA (2000). Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22: 650-659.
11. Elverfors A, Nissbrandt H (1992). Effects of D-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum. Neuropharmacology 31: 661-670.
12. Florin SM, Kuczenski R, Segal DS (1994). Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res 654: 53-62.
13. Franowicz JS, Kessler LE, Borja CM, Kobilka BK, Limbird LE, Arnsten AF (2002). Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J Neurosci 22: 8771-8777.
14. Geranton SM, Heal DJ, Stanford SC (2003). Differences in the mechanisms that increase noradrenaline efflux after administration of D-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus. Br J Pharmacol 139: 1441-1448.
15. Geyer MA, McIlwain KL, Paylor R (2002). Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 7: 1039-1053.
16. Hawk Jr LW, Yartz AR, Pelham Jr WE, Lock TM (2003). The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Psychopharmacology (Berl) 165: 118-127.
17. Heal DJ, Prow MR, Buckett WR (1989). Measurement of 3-methoxy-4- hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function. Br J Pharmacol 96: 547-556.
18. Hein L, Altman JD, Kobilka BK (1999). Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402: 181-184.
19. Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE et al (1997). Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 122: 1339-1344.
20. Ihalainen JA, Tanila H (2002). In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex. Eur J Neurosci 15: 1789-1794.
21. Karoum F, Chrapusta SJ, Brinjak R, Hitri A, Wyatt RJ (1994). Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Br J Pharmacol 113: 1391-1399.
22. Koch M (1999). The neurobiology of startle. Prog Neurobiol 59: 107-128.
23. Kuczenski R (1980). Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism. J Pharmacol Exp Ther 215: 135-142.
24. Kumari V, Cotter P, Corr PJ, Gray JA, Checkley SA (1996). Effect of clonidine on the human acoustic startle reflex. Psychopharmacology 123: 353-360.
25. Lähdesmäki J, Sallinen J, MacDonald E, Kobilka BK, Fagerholm V, Scheinin M (2002). Behavioral and neurochemical characterization of alpha2A-adrenergic receptor knockout mice. Neurosdence 113: 289-299.
26. Lähdesmäki J, Sallinen J, MacDonald E, Sirviö J, Scheinin M (2003). Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. Neuropharmacology 44: 882-892.
27. Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M et al (1997). Substitution of a mutant alpha2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA 94: 9950-9955.
28. Lenard NR, Gettys TW, Dunn AJ (2003). Activation of beta 2- and beta 3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther 305: 653-659.
29. MacDonald E, Scheinin H, Scheinin M (1988). Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. Eur J Pharmacol 158: 119-127.
30. Mansbach RS, Geyer MA, Braff DL (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94: 507-514.
31. Mefford I (1981). Applications of high performance liquid chromatography with electrochemical detection to neurochemical analysis: Measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods 3: 207-224.
32. Morgan CA, Southwick SM, Grillon C, Davis M, Krystal JH, Charney DS (1993). Yohimbine-facilitated acoustic startle reflex in humans. Psychopharmacology 110: 342-346.
33. Morgan CA, Grillon C, Southwick SM, Nagy LM, Davis M, Krystal JH et al (1995). Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder. Psychopharmacology (Berl) 117: 466-471.
34. Nicolaou NM (1980). Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain. Eur J Pharmacol 64: 123-132.
35. Pan WH, Sung JC, Fuh SM (1996). Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. J Pharmacol Exp Ther 278: 725-731.
36. Philipp M, Brede M, Hein L (2002). Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 283: 287-295.
37. Puoliväli J, Björklund M, Holmberg M, Ihalainen JA, Scheinin M, Tanila H (2002). Alpha2C-adrenoceptor mediated regulation of cortical EEG arousal. Neuropharmacology 43: 1305-1312.
38. Ralph RJ, Paulus MP, Geyer MA (2001). Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther 298: 148-155.
39. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998). Adrenergic α2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J Neurosci 18: 3035-3042.
40. Scheibner J, Trendelenburg A, Hein L, Starke K (2001). Alpha(2)-adrenoceptors modulating neuronal serotonin release: a study in alpha(2)-adrenoceptor subtype-deficient mice. Br J Pharmacol 132: 925-933.
41. Schramm NL, McDonald MP, Limbird LE (2001). The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21: 4875-4882.
42. Schulz B, Fendt M, Schnitzler HU (2002). Clonidine injections into the lateral nucleus of the amygdala block acquisition and expression of fear-potentiated startle. Eur J Neurosci 15: 151-157.
43. Segal DS, Kuczenski R (1994). Behavioral pharmacology of amphetamine. In: Cho AK, Segal DS (eds) Amphetamine and its Analogs: Psychopharmacology, Toxicology and Abuse. Academic Press Inc: Orlando. pp 115-150.
44. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35: 409-432.
45. Starke K (2001). Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J Neurochem 78: 685-693.
46. Swerdlow NR, Braff DL, Geyer MA (2000). Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11: 185-204.
47. Trendelenburg AU, Hein L, Gaiser EG, Starke K (1999). Occurrence, pharmacology and function of presynaptic alpha2-autoreceptors in alpha2A/D-adrenoceptor-deficient mice. Naunyn-Schmiedeberg's Arch Pharmacol 360: 540-551.
48. Trendelenburg AU, Klebroff W, Kein L, Starke K (2001). A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and aIpha2C-adrenoceptor-deficient mice. Naunyn-Schmiedeberg's Arch Pharmacol 364: 117-130.
49. Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K (2003). All three alpha(2)-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn-Schmiedeberg's Arch Pharmacol 368: 504-512.
50. Ujike H (2002). Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4: 177-184.
51. Varty GB, Walters N, Cohen-Williams M, Carey GJ (2001). Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur J Pharmacol 424: 27-36.
52. Weinshenker D, Miller NS, Blizinsky K, Laughlin ML, Palmiter RD (2002). Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci USA 99: 13873-13877.
53. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S (2003). Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23: 1879-1885.
54. White DA, Birkle DL (2001). The differential effects of prenatal stress in rats on the acoustic startle reflex under baseline conditions and in response to anxiogenic drugs. Psychopharmacology (Berl) 154: 169-176.
55. Wilens TE, Biederman J, Spencer TJ, Prince J (1995). Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J Clin Psychopharmacol 15: 270-279.
56. Wise RA (1996). Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19: 319-340.
57. Wortley KE, Hughes ZA, Heal DJ, Stanford SC (1999). Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or D-amphetamine: modulation by alpha2-adrenoceptors. Br J Pharmacol 127: 1860-1866.
58. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW et al (2000). Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3: 465-471.
59. Yavich L, Lappalainen R, Sirviö J, Haapalinna A, MacDonald E (1997). Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur J Pharmacol 339: 113-119.